| Terumo Announces European Launch of Biosimilar Using Terumo’s PLAJEX™ Pre-fillable Syringes | https://www.terumo-europe.com/en-emea/news/terumo-announces-european-launch-of-biosimilar-using-terumo’s-plajex™-pre-fillable-syringes | Terumo Announces European Launch of Biosimilar Using Terumo’s PLAJEX™ Pre-fillable Syringes | Tokyo, Japan | 06/12/2018 23:00:00 | <p style="text-align:justify;">Terumo Corporation (TSE: 4543) today announced that a biosimilar, which uses the company's PLAJEX™ pre-fillable syringe, has launched in Europe. Terumo manufactures the product Hulio®, a biosimilar to Humira® (adalimumab), on contract. This marks an important milestone, as the first overseas commercial launch for PLAJEX™.</p> |
| GMP Certification Awarded for the Manufacturing and Filling of Premixed Intravenous Solutions from the FDA (U.S.A.) | https://www.terumo-europe.com/en-emea/news/gmp-certification-awarded-for-the-manufacturing-and-filling-of-premixed-intravenous-solutions-from-the-fda-(u-s-a-) | GMP Certification Awarded for the Manufacturing and Filling of Premixed Intravenous Solutions from the FDA (U.S.A.) | Tokyo, Japan | 13/11/2018 23:00:00 | <p style="text-align:justify;">Terumo Corporation (TSE: 4543) today announced that its Kofu Pharmaceutical Plant in Japan has been conferred Good Manufacturing Practice (GMP) certification on October 18, by the U.S.A. Food and Drug Administration (FDA) for the manufacturing and filling of premixed intravenous solutions.</p> |
| Terumo Receives GMP Certification for the Manufacturing and Filling of Biologics in PLAJEX™ Polymer Pre-fillable Syringes | https://www.terumo-europe.com/en-emea/news/terumo-receives-gmp-certification-for-the-manufacturing-and-filling-of-biologics-in-plajex™-polymer-pre-fillable-syringes | Terumo Receives GMP Certification for the Manufacturing and Filling of Biologics in PLAJEX™ Polymer Pre-fillable Syringes | Tokyo, Japan and Leuven, Belgium | 30/07/2018 22:00:00 | <p>Terumo Announces Receiving European Medicines Agency GMP Certification for the Manufacturing and Filling of Biologics in PLAJEX™ Polymer Pre-fillable Syringes at Yamaguchi Subsidiary’s Plant</p> |
| Terumo Announces Shipping Delays for Products from Ashitaka Factory | https://www.terumo-europe.com/en-emea/news/terumo-announces-shipping-delays-for-products-from-ashitaka-factory | Terumo Announces Shipping Delays for Products from Ashitaka Factory | Tokyo, Japan | 03/07/2018 22:00:00 | <p><span style="font-size:14px;">Terumo Corporation (TSE: 4543) today announced shipping delays for products from its Ashitaka Factory in Shizuoka, Japan. This factory produces certain cardiovascular products. No other Terumo factories are affected by this issue.</span></p> |
| Terumo Acquires CE Marking for Kanshas Drug Coated Balloon Catheter for Lower Extremities | https://www.terumo-europe.com/en-emea/news/terumo-acquires-ce-marking-for-kanshas-drug-coated-balloon-catheter-for-lower-extremities | Terumo Acquires CE Marking for Kanshas Drug Coated Balloon Catheter for Lower Extremities | Tokyo, Japan | 19/06/2018 22:00:00 | <p>Terumo Corporation (TSE: 4543) today announced that it acquired CE marking for the Kanshas™ drug coated balloon (DCB) catheter used in the treatment of lower extremity peripheral arterial disease. With a September launch in Europe, Terumo is expected to be the first Japanese company to launch DCB sales in Europe, and the European launch will be followed with launches in Latin America and Asia, as well. Terumo aims a 10% share of the European DCB market in the future.</p> |
